
Texas-based Integer Holdings designs, develops, and manufactures medical devices and power solutions globally.
Founded in Plano, Texas, Integer Holdings Corporation is dedicated to designing, developing, and manufacturing medical devices and power solutions for both medical and non-medical markets. The company's core mission is to enhance patient care worldwide through innovative and high-quality products. Integer Holdings offers a range of services including rapid prototyping, design and development expertise, and clinical know-how to help clients move seamlessly from concept to production. Their market focus includes providing differentiated performance and portfolio expansion through platform technologies and market-ready products.
Notable figures affiliated with Integer Holdings include industry experts and seasoned professionals in medical device manufacturing. The company has achieved significant milestones in innovation and manufacturing excellence, positioning itself as a leader in the global medical device industry. Integer Holdings' impact is evident in its ability to optimize supply chains through its global R&D and manufacturing capabilities, consistently delivering high-quality solutions that strengthen client innovation and expedite market entry.

Integra LifeSciences

Advanced Medical Device Technologies
advancedmdt.com

Intact Medical

Teleflex
teleflex.com
Intuitive Surgical
intuitive.com

Atrion
atrioncorp.com

Intuitive Surgical

Precision Medical Products
pmpmed.com

Orthofix
orthofix.com

Gilero
gilero.com

Vitaheat Medical

Hospi
hospicorp.com

AngioDynamics
angiodynamics.com

Laborie
laborie.com

Medshift
medshift.com
Companies similar to Integer include Integra LifeSciences, Advanced Medical Device Technologies, Intact Medical and Teleflex.
Integer was founded in 2000.
Integer's headquarters is located in Plano, TX, US.
Integer's most recent funding round was for $435M (USD) in January 2023.
As of Jan 31, 2023, Integer has raised a total of $435M (USD).
Integer has 10,000 employees as of Feb 6, 2024.